164 related articles for article (PubMed ID: 37293163)
61. METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.
Chen HD; Li F; Chen S; Zhong ZH; Gao PF; Gao WZ
Cancer Gene Ther; 2022 Jul; 29(7):1012-1020. PubMed ID: 34799724
[TBL] [Abstract][Full Text] [Related]
62. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
Xia XQ; Lu WL; Ye YY; Chen J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
[TBL] [Abstract][Full Text] [Related]
63. Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover.
Shi X; Guo X; Li X; Wang M; Qin R
Cancer Lett; 2018 Oct; 433():76-85. PubMed ID: 29913236
[TBL] [Abstract][Full Text] [Related]
64. m
Meng X; Deng Y; He S; Niu L; Zhu H
Front Oncol; 2021; 11():629947. PubMed ID: 33680969
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells.
Yu H; Gao M; Ma Y; Wang L; Shen Y; Liu X
Int J Mol Med; 2018 May; 41(5):2573-2588. PubMed ID: 29484384
[TBL] [Abstract][Full Text] [Related]
66. Long intergenic non-protein coding RNA 662 accelerates the progression of gastric cancer through up-regulating centrosomal protein 55 by sponging microRNA-195-5p.
Tao F; Qi L; Liu G
Bioengineered; 2022 Feb; 13(2):3007-3018. PubMed ID: 35037833
[TBL] [Abstract][Full Text] [Related]
67. LINC00662 facilitates osteosarcoma progression via sponging miR-103a-3p and regulating SIK2 expression.
Huang J; Lin F; Xu C; Xu Y
J Tissue Eng Regen Med; 2021 Dec; 15(12):1082-1091. PubMed ID: 34559955
[TBL] [Abstract][Full Text] [Related]
68. WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer.
Li BQ; Liang ZY; Seery S; Liu QF; You L; Zhang TP; Guo JC; Zhao YP
Cancer Lett; 2019 Jun; 451():48-57. PubMed ID: 30851419
[TBL] [Abstract][Full Text] [Related]
69. Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m
Chen M; Zhang Q; Zheng S; Guo X; Cao L; Ren Y; Qian Y; Wang M; Wu X; Xu K
Int J Biol Sci; 2023; 19(5):1616-1632. PubMed ID: 37056933
[TBL] [Abstract][Full Text] [Related]
70. METTL3-Mediated m
Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
[TBL] [Abstract][Full Text] [Related]
71. METTL3-induced UCK2 m
Wu H; Xu H; Jia D; Li T; Xia L
Ann Transl Med; 2021 Jul; 9(14):1155. PubMed ID: 34430596
[TBL] [Abstract][Full Text] [Related]
72. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
73. Pro-Angiogenesis Role of LINC00662 From Esophageal Squamous Cell Carcinoma Cells-Derived Extracellular Vehicles.
Li F; Niu R; Gao S; Zhao F; Dong Z; Zhang H; Li S
Front Bioeng Biotechnol; 2022; 10():772514. PubMed ID: 35433661
[No Abstract] [Full Text] [Related]
74. Methyltransferase-like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway.
Cheng FW; Peng LM; Luo D
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):748-758. PubMed ID: 35434840
[TBL] [Abstract][Full Text] [Related]
75. Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer.
Yuan C; Ding Y; Zhuang Y; Zhang C; Han L; Li W; Guo R; Zhang E
J Cancer; 2022; 13(5):1640-1651. PubMed ID: 35371316
[TBL] [Abstract][Full Text] [Related]
76. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
77. Linc00662 plays an oncogenic role in bladder cancer by sponging miR-199a-5p.
Ma X; Wen Y; Wang Y; Zhang M; Shi L; Wang C; Li Z
Am J Transl Res; 2021; 13(11):12673-12683. PubMed ID: 34956482
[TBL] [Abstract][Full Text] [Related]
78. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
[TBL] [Abstract][Full Text] [Related]
79. Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression.
Wang B; Xu Z; Wang X; Xia S; Cai P; Wang M; Gao Z
J Orthop Surg Res; 2022 Feb; 17(1):74. PubMed ID: 35123530
[TBL] [Abstract][Full Text] [Related]
80. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
